<VariationArchive RecordType="classified" VariationID="3553" VariationName="NG_008654.2:g.(13298_14630)_(15199_19425)del" VariationType="Deletion" Accession="VCV000003553" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-02-18" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18592" VariationID="3553">
      <GeneList>
        <Gene Symbol="CLN3" FullName="CLN3 lysosomal/endosomal transmembrane protein, battenin" GeneID="1201" HGNC_ID="HGNC:2074" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>16p12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="28466653" stop="28492082" display_start="28466653" display_stop="28492082" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="28488599" stop="28503622" display_start="28488599" display_stop="28503622" Strand="-" />
          </Location>
          <OMIM>607042</OMIM>
        </Gene>
      </GeneList>
      <Name>NG_008654.2:g.(13298_14630)_(15199_19425)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p12.1</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>3-KB DEL, NT928</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008654.2" sequenceAccession="NG_008654" sequenceVersion="2" change="g.(13298_14630)_(15199_19425)del">
            <Expression>NG_008654.2:g.(13298_14630)_(15199_19425)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_689" sequenceAccession="LRG_689">
            <Expression>LRG_689:g.(13298_14630)_(15199_19425)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="607042.0002" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_008654.2:g.(13298_14630)_(15199_19425)del AND Neuronal ceroid lipofuscinosis 3" Accession="RCV000003732" Version="2">
        <ClassifiedConditionList TraitSetID="926">
          <ClassifiedCondition DB="MedGen" ID="C0751383">Neuronal ceroid lipofuscinosis 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-09-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-09-22" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2013-04-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7553855</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="926" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="768" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spielmeyer Sjogren disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuronal ceroid lipofuscinosis 3</ElementValue>
                <XRef ID="MONDO:0008767" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CLN3-Related Neuronal Ceroid-Lipofuscinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CLN3 Disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLN3</ElementValue>
                <XRef Type="MIM" ID="204200" DB="OMIM" />
              </Symbol>
              <XRef ID="228346" DB="Orphanet" />
              <XRef ID="C0751383" DB="MedGen" />
              <XRef ID="MONDO:0008767" DB="MONDO" />
              <XRef Type="MIM" ID="204200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23895" SubmissionDate="2012-06-05" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607042.0002_CEROID LIPOFUSCINOSIS, NEURONAL, 3" title="CLN3, 3-KB DEL, NT928_CEROID LIPOFUSCINOSIS, NEURONAL, 3" />
        <ClinVarAccession Accession="SCV000023895" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-09-22">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Finnish patient with Batten disease (204200), the International Batten Disease Consortium (1995) identified compound heterozygosity for 2 deletions in the CLN3 gene: the 1.02-kb deletion (607042.0001) and a 3-kb deletion resulting in a 266-bp coding sequence deletion (nucleotides 928-1193), resulting in a truncated protein with the first 263 amino acids of CLN3 followed by 28 novel amino acids before a stop codon.</Attribute>
              <Citation>
                <ID Source="PubMed">7553855</ID>
              </Citation>
              <XRef DB="OMIM" ID="204200" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLN3" />
          </GeneList>
          <Name>CLN3, 3-KB DEL, NT928</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-KB DEL, NT928</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607042.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEROID LIPOFUSCINOSIS, NEURONAL, 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23895" TraitType="Disease" MappingType="Name" MappingValue="CEROID LIPOFUSCINOSIS, NEURONAL, 3" MappingRef="Preferred">
        <MedGen CUI="C0751383" Name="Neuronal ceroid lipofuscinosis 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

